Akuttherapie anaphylaktischer Reaktionen Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umwelt- medizin (GPA) und der Deutschen Akademie für Allergologie und

[1]  W. Pichler,et al.  Anstrengungsinduzierte Urtikaria und Anaphylaxie , 2008 .

[2]  Nadine Shehab,et al.  Safety of Angiotensin-Converting Enzyme Inhibitors in Patients with Insect Venom Allergies , 2006, The Annals of pharmacotherapy.

[3]  B. Niggemann,et al.  Anaphylactic reactions in children – a questionnaire‐based survey in Germany , 2005, Allergy.

[4]  Joseph Beyene,et al.  Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death , 2005, Annals of Internal Medicine.

[5]  D. Moneret-vautrin,et al.  Epidemiology of life‐threatening and lethal anaphylaxis: a review , 2005, Allergy.

[6]  D. Hepner,et al.  Symposium on the definition and management of anaphylaxis: summary report. , 2005, The Journal of allergy and clinical immunology.

[7]  U. Müller,et al.  Use of β-blockers during immunotherapy for Hymenoptera venom allergy , 2005 .

[8]  C. Kill,et al.  Successful Treatment of Severe Anaphylactic Shock with Vasopressin , 2004, International Archives of Allergy and Immunology.

[9]  John B Wong,et al.  Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. , 2004, The Journal of allergy and clinical immunology.

[10]  F. Simons,et al.  First-aid treatment of anaphylaxis to food: focus on epinephrine. , 2004, The Journal of allergy and clinical immunology.

[11]  Thomas Bieber,et al.  Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. , 2004, The Journal of allergy and clinical immunology.

[12]  T. Fuchs,et al.  Insektengiftallergie , 2004 .

[13]  B. Böttiger,et al.  Anaphylaktoide Reaktionen in der Prähospitalphase , 2004, Der Internist.

[14]  R. Heddle,et al.  Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation , 2004, Emergency Medicine Journal.

[15]  W. Pichler,et al.  Incidence of anaphylaxis with circulatory symptoms: a study over a 3‐year period comprising 940 000 inhabitants of the Swiss Canton Bern , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  C. Camargo,et al.  Multicenter study of emergency department visits for food allergies. , 2004, The Journal of allergy and clinical immunology.

[17]  A. Bircher,et al.  Selbstbehandlung mit Notfallmedikamenten bei schweren allergischen Reaktionen , 2003 .

[18]  D. Hepner,et al.  Anaphylaxis During the Perioperative Period , 2003, Anesthesia and analgesia.

[19]  F. Simons,et al.  H1-Antihistamines: more relevant than ever in the treatment of allergic disorders. , 2003, The Journal of allergy and clinical immunology.

[20]  G. W. Canonica,et al.  Consensus group on new‐generation antihistamines (CONGA): present status and recommendations , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  I. Celik,et al.  Early and late histamine release induced by albumin, hetastarch and polygeline: some unexpected findings , 2003, Inflammation Research.

[22]  J. H. Day,et al.  Diagnosis and management of anaphylaxis. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[23]  P. Lieberman.  Use of epinephrine in the treatment of anaphylaxis , 2003, Current opinion in allergy and clinical immunology.

[24]  J. Boldt,et al.  Intravascular Volume Replacement Therapy with Synthetic Colloids: Is There an Influence on Renal Function? , 2003, Anesthesia and analgesia.

[25]  F. Simons,et al.  Clinical pharmacology of H1-antihistamines in the skin. , 2002, The Journal of allergy and clinical immunology.

[26]  R. Lockey,et al.  Anaphylaxis: a review of causes and mechanisms. , 2002, The Journal of allergy and clinical immunology.

[27]  F. Simons,et al.  Is epinephrine administration by sublingual tablet feasible for the first‐aid treatment of anaphylaxis? A proof‐of‐concept study , 2002, Biopharmaceutics & drug disposition.

[28]  U. Mehlhorn,et al.  Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery , 2002, Critical Care.

[29]  J. A. Grant,et al.  A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[30]  F. Simons,et al.  Epinephrine absorption in adults: intramuscular versus subcutaneous injection. , 2001, The Journal of allergy and clinical immunology.

[31]  G. Clough,et al.  Comparison of the effects of levocetirizine and loratadine on histamine‐induced wheal, flare, and itch in human skin , 2001, Allergy.

[32]  T. Fuchs,et al.  Die spezifische Immuntherapie (Hyposensibilisierung) mit Allergenen1 , 2001 .

[33]  L. Schwartz.  Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. , 2001, Leukemia research.

[34]  B. Wüthrich,et al.  Food‐induced anaphylaxis , 2001, Allergy.

[35]  B. Przybilla,et al.  Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings , 2001, The Lancet.

[36]  R. Bellomo,et al.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial , 2000, The Lancet.

[37]  R. Lin,et al.  Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. , 2000, Annals of emergency medicine.

[38]  K. Simons,et al.  Can Epinephrine Inhalations Be Substituted for Epinephrine Injection in Children at Risk for Systemic Anaphylaxis? , 2000, Pediatrics.

[39]  Pumphrey.  Lessons for management of anaphylaxis from a study of fatal reactions , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[40]  A. Sheikh,et al.  Hospital admissions for acute anaphylaxis: time trend study , 2000, BMJ : British Medical Journal.

[41]  J. Ring,et al.  Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. , 1999, The Journal of allergy and clinical immunology.

[42]  J. Boldt.  Volumenersatz beim schwerkranken Intensivpatienten Keine klassische Übersicht , 1998, Der Anaesthesist.

[43]  W. Pichler,et al.  [Anaphylaxis: clinical aspects, etiology and course in 118 patients]. , 1998, Schweizerische medizinische Wochenschrift.

[44]  J. Ring,et al.  The renin-angiotensin system in patients with repeated anaphylactic reactions during hymenoptera venom hyposensitization and sting challenge. , 1997, International archives of allergy and immunology.

[45]  H. Malling,et al.  Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. , 1996, The Journal of allergy and clinical immunology.

[46]  C. Ohmann,et al.  Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia , 1994, The Lancet.

[47]  U. Müller,et al.  Reduction of side effects from rush‐immunotherapy with honey bee venom by pretreatment with terfenadine , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[48]  J. Bousquet,et al.  Emergency treatment of allergic reactions to Hymenoptera stings , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[49]  R. Patterson,et al.  The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. , 1991, The Journal of allergy and clinical immunology.

[50]  P. Allain,et al.  Réactions anaphylactoïdes graves après corticoïdes intraveineux. A propos d'un cas et revue de la littérature. , 1990 .

[51]  J. Anderson,et al.  Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections. , 1990, The Journal of allergy and clinical immunology.

[52]  W. Lorenz,et al.  Perioperative uses of histamine antagonists. , 1990, Journal of clinical anesthesia.

[53]  H. Huchzermeyer,et al.  Histaminwirkungen am Herzen unter besonderer Berücksichtigung kardialer Nebenwirkungen von H2-Rezeptor-Antagonisten , 1989, Klinische Wochenschrift.

[54]  P. Turk,et al.  Cimetidine in anaphylactic shock refractory to standard therapy. , 1989, Anesthesia and analgesia.

[55]  S. Gross,et al.  Adenosine promotes histamine H1-mediated negative chronotropic and inotropic effects on human atrial myocardium. , 1988, The Journal of pharmacology and experimental therapeutics.

[56]  B. Chernow,et al.  Glucagon reversal of hypotension in a case of anaphylactoid shock. , 1986, Annals of internal medicine.

[57]  T. Sullivan,et al.  Biphasic and protracted anaphylaxis. , 1986, The Journal of allergy and clinical immunology.

[58]  M. Brown,et al.  Hypokalemia from beta 2-receptor stimulation by circulating epinephrine. , 1983, The American journal of cardiology.

[59]  J. Ring,et al.  ANAPHYLAXIS TO ETHANOL AND SENSITISATION TO ACETIC ACID , 1983, The Lancet.

[60]  T. J. Sullivan.  Cardiac disorders in penicillin-induced anaphylaxis. Association with intravenous epinephrine therapy. , 1982, JAMA.

[61]  A. Wegmann,et al.  Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions , 1982, Klinische Wochenschrift.

[62]  P. L. Smith,et al.  Physiologic manifestations of human anaphylaxis. , 1980, The Journal of clinical investigation.

[63]  J. Ring,et al.  Effects of radiopaque contrast media on the microcirculation of the rabbit omentum. , 1979, Radiology.

[64]  D. Pratt,et al.  Exercise-induced anaphylactic reaction to shellfish. , 1979, The Journal of allergy and clinical immunology.

[65]  K. Arfors,et al.  Anaphylaxis in the monkey: hemodynamics and blood flow distribution. , 1979, Acta Physiologica Scandinavica.

[66]  J. Ring,et al.  INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTES , 1977, The Lancet.

[67]  R. Levi,et al.  The heart as a target organ in systemic allergic reactions: comparison of cardiac analphylaxis in vivo and in vitro. , 1975, Circulation research.

[68]  J. H. Barnard.  Studies of 400 Hymenoptera sting deaths in the United States. , 1973, The Journal of allergy and clinical immunology.

[69]  C. Delage,et al.  Anaphylactic deaths: a clinicopathologic study of 43 cases. , 1972, Journal of forensic sciences.

[70]  J. Boldt,et al.  Renal dysfunction after hydroxyethyl starch. Authors' reply , 2004 .

[71]  A. Ranft,et al.  Therapie anaphylaktischer Reaktionen: Synopsis bestehender Leitlinien und Empfehlungen , 2004 .

[72]  H. Behrendt,et al.  Anaphylaxis and anaphylactoid reactions , 1987 .

[73]  H. Löllgen,et al.  Akuttherapie anaphylaktoider Reaktionen: Ergebnisse einer interdisziplinären Consensuskonferenz , 1994 .

[74]  J. Toogood.  Risk of anaphylaxis in patients receiving beta-blocker drugs. , 1988, The Journal of allergy and clinical immunology.

[75]  D. Kleinhans.  Anstrengungsinduzierte Urtikaria und Anaphylaxie , 1987 .

[76]  J. Ring,et al.  Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial. , 1985, International archives of allergy and applied immunology.